Qais Mekki

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole*

Leslie Carstensen Floren, Ihor Bekersky, Leslie Z. Benet et al. · Clinical Pharmacology & Therapeutics · 1997 · 267 citations

Pharmacokinetics of tacrolimus in liver transplant patients*

William J. Jusko, Wojciech Piekoszewski, Göran B. Klintmalm et al. · Clinical Pharmacology & Therapeutics · 1995 · 238 citations

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control

Ralph A. DeFronzo, P. Fleck, Craig Wilson et al. · Diabetes Care · 2008 · 224 citations · Full text

Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study

Michael A. Nauck, Graham C. Ellis, P. Fleck et al. · International Journal of Clinical Practice · 2008 · 203 citations · Full text

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA _1c without causing weight gain or increased hypoglycaemia

Julio Rosenstock, Marc Rendell, Jorge Luiz Gross et al. · Diabetes Obesity and Metabolism · 2009 · 188 citations